Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Beal MF, Martin JB. Effects of lesions on somatostatin-like immunoreactivity in the rat striatum. Brain Res. 1983 Apr 25;266(1):67-73. doi: 10.1016/0006-8993(83)91309-4. PubMed PMID: 6133592.
Beal MF, Domesick VB, Martin JB. Regional somatostatin distribution in the rat striatum. Brain Res. 1983 Nov 14;278(1-2):103-8. doi: 10.1016/0006-8993(83)90228-7. PubMed PMID: 6139149.
Sagar SM, Beal MF, Marshall PE, Landis DM, Martin JB. Implications of neuropeptides in neurological diseases. Peptides. 1984;5 Suppl 1:255-62. doi: 10.1016/0196-9781(84)90284-5. Review. PubMed PMID: 6207511.
Beal MF, Martin JB. The effect of somatostatin on striatal catecholamines. Neurosci Lett. 1984 Feb 24;44(3):271-6. doi: 10.1016/0304-3940(84)90034-x. PubMed PMID: 6145120.
Beal MF, Bird ED, Langlais PJ, Martin JB. Somatostatin is increased in the nucleus accumbens in Huntington's disease. Neurology. 1984 May;34(5):663-6. doi: 10.1212/wnl.34.5.663. PubMed PMID: 6143284.
Beal MF, Martin JB. Effects of neuroleptic drugs on brain somatostatin-like-immunoreactivity. Neurosci Lett. 1984 Jun 15;47(2):125-30. doi: 10.1016/0304-3940(84)90417-8. PubMed PMID: 6146954.
Beal MF, Martin JB. Depletion of striatal somatostatin by local cysteamine injection. Brain Res. 1984 Aug 13;308(2):319-24. doi: 10.1016/0006-8993(84)91071-0. PubMed PMID: 6148124.
Beal MF, Fisher J, Carr DB, Martin JB. Effects of neuroleptic drugs on brain beta-endorphin immunoreactivity. Neurosci Lett. 1985 Jan 21;53(2):173-8. doi: 10.1016/0304-3940(85)90181-8. PubMed PMID: 2858834.
Beal MF, Domesick VB, Martin JB. Effects of lesions in the amygdala and periventricular hypothalamus on striatal somatostatin-like immunoreactivity. Brain Res. 1985 Mar 25;330(2):309-16. doi: 10.1016/0006-8993(85)90690-0. PubMed PMID: 3986546.
Tran VT, Beal MF, Martin JB. Two types of somatostatin receptors differentiated by cyclic somatostatin analogs. Science. 1985 Apr 26;228(4698):492-5. doi: 10.1126/science.2858917. PubMed PMID: 2858917.
Beal MF, Benoit R, Bird ED, Martin JB. Immunoreactive somatostatin-28(1-12) is increased in Huntington's disease. Neurosci Lett. 1985 May 23;56(3):377-80. doi: 10.1016/0304-3940(85)90272-1. PubMed PMID: 2862613.
Beal MF, Mazurek MF, Tran VT, Chattha G, Bird ED, Martin JB. Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease. Science. 1985 Jul 19;229(4710):289-91. doi: 10.1126/science.2861661. PubMed PMID: 2861661.
Kowall NW, Beal MF, Ferrante RJ, Martin JB. Topography of nicotinamide adenine dinucleotide phosphate-diaphorase staining neurons in rat striatum. Neurosci Lett. 1985 Aug 16;59(1):61-6. doi: 10.1016/0304-3940(85)90215-0. PubMed PMID: 2931630.
Ferrante RJ, Kowall NW, Beal MF, Richardson EP Jr, Bird ED, Martin JB. Selective sparing of a class of striatal neurons in Huntington's disease. Science. 1985 Nov 1;230(4725):561-3. doi: 10.1126/science.2931802. PubMed PMID: 2931802.
Beal MF, Mazurek MF, Black PM, Martin JB. Human cerebrospinal fluid somatostatin in neurologic disease. J Neurol Sci. 1985 Nov;71(1):91-104. doi: 10.1016/0022-510x(85)90039-5. PubMed PMID: 2868070.
Beal MF, Martin JB. Topographical dopamine and serotonin distribution and turnover in rat striatum. Brain Res. 1985 Dec 9;358(1-2):10-5. doi: 10.1016/0006-8993(85)90942-4. PubMed PMID: 2416384.
Beal MF, Marshall PE, Burd GD, Landis DM, Martin JB. Excitotoxin lesions do not mimic the alteration of somatostatin in Huntington's disease. Brain Res. 1985 Dec 30;361(1-2):135-45. doi: 10.1016/0006-8993(85)91283-1. PubMed PMID: 2867808.
Beal MF, Uhl G, Mazurek MF, Kowall N, Martin JB. Somatostatin: alterations in the central nervous system in neurological diseases. Res Publ Assoc Res Nerv Ment Dis. 1986;64:215-57. Review. PubMed PMID: 2873636.
Beal MF, Growdon JH, Mazurek MF, Martin JB. CSF somatostatin-like immunoreactivity in dementia. Neurology. 1986 Feb;36(2):294-7. doi: 10.1212/wnl.36.2.294. PubMed PMID: 2868429.
Beal MF, Tran VT, Mazurek MF, Chattha G, Martin JB. Somatostatin binding sites in human and monkey brain: localization and characterization. J Neurochem. 1986 Feb;46(2):359-65. doi: 10.1111/j.1471-4159.1986.tb12976.x. PubMed PMID: 2867123.
Beal MF, Mazurek MF, Lorenz LJ, Chattha GK, Ellison DW, Martin JB. An examination of neuropeptide Y postmortem stability in an animal model simulating human autopsy conditions. Neurosci Lett. 1986 Feb 14;64(1):69-74. doi: 10.1016/0304-3940(86)90665-8. PubMed PMID: 3754317.
Beal MF, Benoit R, Mazurek MF, Bird ED, Martin JB. Somatostatin-28(1-12)-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex. Brain Res. 1986 Mar 19;368(2):380-3. doi: 10.1016/0006-8993(86)90586-x. PubMed PMID: 2870772.
Beal MF, Kowall NW, Ellison DW, Mazurek MF, Swartz KJ, Martin JB. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature. 1986 May 8-14;321(6066):168-71. doi: 10.1038/321168a0. PubMed PMID: 2422561.
Mair RG, Langlais PJ, Mazurek MF, Beal MF, Martin JB, McEntee WJ. Reduced concentrations of arginine vasopressin and MHPG in lumbar CSF of patients with Korsakoff's psychosis. Life Sci. 1986 Jun 23;38(25):2301-6. doi: 10.1016/0024-3205(86)90636-3. PubMed PMID: 2425205.
Beal MF, Chattha GK, Martin JB. A comparison of regional somatostatin and neuropeptide Y distribution in rat striatum and brain. Brain Res. 1986 Jul 9;377(2):240-5. doi: 10.1016/0006-8993(86)90864-4. PubMed PMID: 3755369.
Mazurek MF, Growdon JH, Beal MF, Martin JB. CSF vasopressin concentration is reduced in Alzheimer's disease. Neurology. 1986 Aug;36(8):1133-7. doi: 10.1212/wnl.36.8.1133. PubMed PMID: 3736884.
Black PM, Ballantine HT Jr, Carr DB, Beal MF, Martin JB. Beta-endorphin and somatostatin concentrations in the ventricular cerebrospinal fluid of patients with affective disorder. Biol Psychiatry. 1986 Sep;21(11):1077-81. doi: 10.1016/0006-3223(86)90290-8. PubMed PMID: 2874844.
Beal MF, Mazurek MF, Chattha GK, Svendsen CN, Bird ED, Martin JB. Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease. Ann Neurol. 1986 Sep;20(3):282-8. doi: 10.1002/ana.410200303. PubMed PMID: 3767313.
Beal MF, Mazurek MF, Svendsen CN, Bird ED, Martin JB. Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease. Ann Neurol. 1986 Oct;20(4):489-95. doi: 10.1002/ana.410200408. PubMed PMID: 3789664.
Beal MF, Frank RC, Ellison DW, Martin JB. The effect of neuropeptide Y on striatal catecholamines. Neurosci Lett. 1986 Oct 30;71(1):118-23. doi: 10.1016/0304-3940(86)90267-3. PubMed PMID: 2431356.
Beal MF, Martin JB. Neuropeptides in neurological disease. Ann Neurol. 1986 Nov;20(5):547-65. doi: 10.1002/ana.410200502. Review. PubMed PMID: 2947536.
Ellison DW, Beal MF, Mazurek MF, Bird ED, Martin JB. A postmortem study of amino acid neurotransmitters in Alzheimer's disease. Ann Neurol. 1986 Nov;20(5):616-21. doi: 10.1002/ana.410200510. PubMed PMID: 2878639.
Mazurek MF, Beal MF, Martin JB. Neuropeptides in Alzheimer's disease. Clinical implications. Neurol Clin. 1986 Nov;4(4):753-68. Review. PubMed PMID: 3025582.
Beal MF, Mazurek MF, Martin JB. Somatostatin immunoreactivity is reduced in Parkinson's disease dementia with Alzheimer's changes. Brain Res. 1986 Nov 12;397(2):386-8. doi: 10.1016/0006-8993(86)90644-x. PubMed PMID: 3801878.
Mazurek MF, Beal MF, Bird ED, Martin JB. Vasopressin in Alzheimer's disease: a study of postmortem brain concentrations. Ann Neurol. 1986 Dec;20(6):665-70. doi: 10.1002/ana.410200603. PubMed PMID: 3813496.
Ferrante RJ, Kowall NW, Beal MF, Martin JB, Bird ED, Richardson EP Jr. Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J Neuropathol Exp Neurol. 1987 Jan;46(1):12-27. doi: 10.1097/00005072-198701000-00002. PubMed PMID: 2947977.
Kowall NW, Ferrante RJ, Beal MF, Richardson EP Jr, Sofroniew MV, Cuello AC, Martin JB. Neuropeptide Y, somatostatin, and reduced nicotinamide adenine dinucleotide phosphate diaphorase in the human striatum: a combined immunocytochemical and enzyme histochemical study. Neuroscience. 1987 Mar;20(3):817-28. doi: 10.1016/0306-4522(87)90242-9. PubMed PMID: 2885780.
Beal MF, Mazurek MF, Martin JB. A comparison of somatostatin and neuropeptide Y distribution in monkey brain. Brain Res. 1987 Mar 10;405(2):213-9. doi: 10.1016/0006-8993(87)90290-3. PubMed PMID: 3567602.
Ellison DW, Beal MF, Martin JB. Amino acid neurotransmitters in postmortem human brain analyzed by high performance liquid chromatography with electrochemical detection. J Neurosci Methods. 1987 Apr;19(4):305-15. doi: 10.1016/0165-0270(87)90073-2. PubMed PMID: 2884352.
Tatsuoka Y, Riskind PN, Beal MF, Martin JB. The effect of amphetamine on the in vivo release of dopamine, somatostatin and neuropeptide Y from rat caudate nucleus. Brain Res. 1987 May 12;411(1):200-3. doi: 10.1016/0006-8993(87)90702-5. PubMed PMID: 2886182.
Ferrante RJ, Beal MF, Kowall NW, Richardson EP Jr, Martin JB. Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease. Brain Res. 1987 May 12;411(1):162-6. doi: 10.1016/0006-8993(87)90694-9. PubMed PMID: 2955849.
Mazurek MF, Beal MF, Bird ED, Martin JB. Oxytocin in Alzheimer's disease: postmortem brain levels. Neurology. 1987 Jun;37(6):1001-3. doi: 10.1212/wnl.37.6.1001. PubMed PMID: 3587615.
Beal MF, Svendsen CN, Bird ED, Martin JB. Somatostatin and neuropeptide Y are unaltered in the amygdala in schizophrenia. Neurochem Pathol. 1987 Jun;6(3):169-76. doi: 10.1007/bf02834198. PubMed PMID: 2888067.
Ellison DW, Beal MF, Martin JB. Phosphoethanolamine and ethanolamine are decreased in Alzheimer's disease and Huntington's disease. Brain Res. 1987 Aug 11;417(2):389-92. doi: 10.1016/0006-8993(87)90471-9. PubMed PMID: 2958109.
Ellison DW, Beal MF, Mazurek MF, Malloy JR, Bird ED, Martin JB. Amino acid neurotransmitter abnormalities in Huntington's disease and the quinolinic acid animal model of Huntington's disease. Brain. 1987 Dec;110 ( Pt 6):1657-73. doi: 10.1093/brain/110.6.1657. PubMed PMID: 2892568.
Beal MF, Ellison DW, Mazurek MF, Swartz KJ, Malloy JR, Bird ED, Martin JB. A detailed examination of substance P in pathologically graded cases of Huntington's disease. J Neurol Sci. 1988 Mar;84(1):51-61. doi: 10.1016/0022-510x(88)90173-6. PubMed PMID: 2452859.
Gabriel SM, MacGarvey UM, Koenig JI, Swartz KJ, Martin JB, Beal MF. Characterization of galanin-like immunoreactivity in the rat brain: effects of neonatal glutamate treatment. Neurosci Lett. 1988 Apr 22;87(1-2):114-21. doi: 10.1016/0304-3940(88)90155-3. PubMed PMID: 2454423.
Beal MF, Mazurek MF, Ellison DW, Swartz KJ, McGarvey U, Bird ED, Martin JB. Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington's disease. Ann Neurol. 1988 Jun;23(6):562-9. doi: 10.1002/ana.410230606. PubMed PMID: 2900622.
Beal MF, Swartz KJ, Finn SF, Bird ED, Martin JB. Amino acid and neuropeptide neurotransmitters in Huntington's disease cerebellum. Brain Res. 1988 Jun 28;454(1-2):393-6. doi: 10.1016/0006-8993(88)90844-x. PubMed PMID: 2457409.
Beal MF, Kowall NW, Swartz KJ, Ferrante RJ, Martin JB. Response:Model of Huntington's disease. Science. 1988 Jul 22;241(4864):475. doi: 10.1126/science.241.4864.475. PubMed PMID: 17792612.
What would you like to do?